All subjects enrolled in LiiRA will receive certolizumab (Cimzia) at no cost. Certolizumab (Cimzia) is part of a family of treatments called tumor necrosis factor inhibitors (TNFi) used to treat rheumatoid arthritis.
How does Cimzia work?
TNFi medications stop the immune system’s attack on the joints. They do this by blocking the action of tumor necrosis factor, which is involved in inflammation.
How do I use Cimzia?
Cimzia comes in pre-filled syringe that is injected into the lower abdomen or upper thigh region every other week. Each patient will be shown how to inject the pre-filled syringe by a nurse and will be given proper disposal instructions. Once used, the pre-filled syringe must NOT be re-capped and be place into the given sharps container. Once the sharps container is full, you can dispose of the container by your town or city guidelines.